摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-amino-1-(2-chloro-4-fluorobenzyl)piperidine | 380424-72-6

中文名称
——
中文别名
——
英文名称
4-amino-1-(2-chloro-4-fluorobenzyl)piperidine
英文别名
1-[(2-Chloro-4-fluorophenyl)methyl]piperidin-4-amine
4-amino-1-(2-chloro-4-fluorobenzyl)piperidine化学式
CAS
380424-72-6
化学式
C12H16ClFN2
mdl
MFCD12137398
分子量
242.724
InChiKey
WLMUBAJRXMQQNI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    311.7±42.0 °C(Predicted)
  • 密度:
    1.216±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    29.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-amino-1-(2-chloro-4-fluorobenzyl)piperidine 在 sodium hydroxide 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 5.0h, 生成 1-(2-chloro-4-fluorobenzyl)piperidin-4-ylthiourea
    参考文献:
    名称:
    Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer’s Agents: Synthesis and Biological Evaluation
    摘要:
    A novel series of hybrid molecules were designed and synthesized by fusing the pharmacophoric features of cholinesterase inhibitor donepezil and diarylthiazole as potential multitarget-directed ligands for the treatment of Alzheimer's disease (AD). The compounds showed significant in vitro anticholinesterase (anti-ChE) activity, the most potent compound (44) among them showing the highest activity (IC50 value of 0.30 +/- 0.01 mu M) for AChE and (1.84 +/- 0.03 mu M) for BuChE. Compound 44 showed mixed inhibition of AChE in the enzyme kinetic studies. Some compounds exhibited moderate to high inhibition of AChE-induced A beta(1-42) aggregation and noticeable in vitro antioxidant and antiapoptotic properties. Compound 44 showed significant in vivo anti-ChE and antioxidant activities. Furthermore, compound 44 demonstrated in vivo neuroprotection by decreasing A beta(1-42)-induced toxicity by attenuating abnormal levels of A beta(1-42), p-Tau, cleaved caspase-3, and cleaved PARP proteins. Compound 44 exhibited good oral absorption and was well tolerated up to 2000 mg/kg, po, dose without showing toxic effects.
    DOI:
    10.1021/acs.jmedchem.6b00426
  • 作为产物:
    参考文献:
    名称:
    Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer’s Agents: Synthesis and Biological Evaluation
    摘要:
    A novel series of hybrid molecules were designed and synthesized by fusing the pharmacophoric features of cholinesterase inhibitor donepezil and diarylthiazole as potential multitarget-directed ligands for the treatment of Alzheimer's disease (AD). The compounds showed significant in vitro anticholinesterase (anti-ChE) activity, the most potent compound (44) among them showing the highest activity (IC50 value of 0.30 +/- 0.01 mu M) for AChE and (1.84 +/- 0.03 mu M) for BuChE. Compound 44 showed mixed inhibition of AChE in the enzyme kinetic studies. Some compounds exhibited moderate to high inhibition of AChE-induced A beta(1-42) aggregation and noticeable in vitro antioxidant and antiapoptotic properties. Compound 44 showed significant in vivo anti-ChE and antioxidant activities. Furthermore, compound 44 demonstrated in vivo neuroprotection by decreasing A beta(1-42)-induced toxicity by attenuating abnormal levels of A beta(1-42), p-Tau, cleaved caspase-3, and cleaved PARP proteins. Compound 44 exhibited good oral absorption and was well tolerated up to 2000 mg/kg, po, dose without showing toxic effects.
    DOI:
    10.1021/acs.jmedchem.6b00426
点击查看最新优质反应信息

文献信息

  • 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
    申请人:——
    公开号:US20030105098A1
    公开(公告)日:2003-06-05
    The present invention comprises 6-9-Disubstituted 2-[trans-(4-aminocyclohexyl]aminopurines that are useful in inhibiting cyclin dependent kinases, particularly cdk-2. The present invention also provides a method of preventing apoptosis in neuronal cells and a method of inhibiting the development of neoplasms.
    本发明涉及6-9-二取代的2- [转-(4-氨基环己基)]氨基嘌呤,其在抑制细胞周期依赖性激酶,特别是cdk-2方面具有用途。本发明还提供了一种预防神经细胞凋亡和抑制肿瘤发展的方法。
  • THE DESIGN AND SYNTHESIS OF PURINE INHIBITORS OF CDK2. III
    作者:P. W. Shum、N. P. Peet、P. M. Weintraub、T. B. Le、Z. Zhao、F. Barbone、B. Cashman、J. Tsay、S. Dwyer、P. C. Loos、E. A. Powers、K. Kropp、P. S. Wright、A. Bitonti、J. Dumont、D. R. Borcherding
    DOI:10.1081/ncn-100002493
    日期:2001.3.31
    Cyclin-dependent kinases (CDKs) belong to a class of enzymes that control the ability of a cell to enter into and proceed through the cell division cycle. Using purine as a scaffold, we have synthesized a number of nanomolar inhibitors of CDK-2/cyclin E. In this report, the synthesis of a series of piperidine-substituted purine analogs will be presented, as well as some of their in vitro and in vivo biological effects.
  • 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES
    申请人:Aventis Pharmaceuticals Inc.
    公开号:EP1056744B1
    公开(公告)日:2003-10-22
  • US6479487B1
    申请人:——
    公开号:US6479487B1
    公开(公告)日:2002-11-12
  • US6642231B2
    申请人:——
    公开号:US6642231B2
    公开(公告)日:2003-11-04
查看更多